Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-04-23 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
独立董事2022年度述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Directors 2022 Annual Report" from Ningbo New Century Biotechnology Co., Ltd. It details the attendance of independent directors at board and shareholder meetings, their independent opinions on various company matters, their supervisory activities, and training attended. The content focuses on the independent directors' duties, opinions, and governance oversight during the year 2022. It does not contain financial statements or quarterly/annual financial results, nor is it an announcement of voting results or a proxy solicitation. It is a report on board/management information specifically about independent directors' activities and governance roles. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not a mere announcement of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2023-04-23 Chinese
拟续聘会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (立信会计师事务所) as the auditor for the company's 2023 annual audit. It includes details about the accounting firm, its qualifications, past audit fees, and the board and audit committee's approval of the proposal. There are no actual financial statements or audit reports included, only information about the appointment process and related approvals. The document length is 3365 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates specifically to audit matters but does not contain the full audit report itself, nor is it a regulatory filing or report publication announcement. The content focuses on audit firm reappointment details, which fits the AR category. FY 2023
2023-04-23 Chinese
独立董事关于第八届董事会第三次会议独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on several proposals discussed at the company's eighth board meeting, including the 2022 annual equity distribution plan, reappointment of the audit firm, a special report on the use of raised funds, and a share repurchase plan. It contains no financial statements or detailed financial data but rather opinions and approvals related to governance and corporate actions. The document is short (1521 characters) and serves as a formal announcement of independent directors' opinions on board meeting matters, not a full report or financial statement. This fits best under Board/Management Information (MANG), which covers announcements related to board or management decisions and opinions.
2023-04-23 Chinese
关于召开2022年年度股东大会通知公告（提供网络投票）
AGM Information Classification · 95% confidence The document is a notice announcing the convening of the 2022 Annual General Meeting (AGM) of Ningbo Scientz Biotechnology Co., Ltd. It details the meeting date, voting methods (including online voting), agenda items to be discussed at the AGM such as the 2022 board work report, supervisory board report, independent director report, financial statements, annual report, dividend distribution plan, and other proposals. The document also provides procedural information about registration and attendance. It does not contain the actual reports or financial data but references where these can be found. The document length is 3451 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or notices about the AGM.
2023-04-23 Chinese
第八届监事会第三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Ningbo New Century Biotechnology Co., Ltd. It details the meeting held on April 20, 2023, including the review and approval of various reports such as the 2022 Annual Report, Supervisory Board Work Report, Financial Final Accounts Report, Equity Distribution Plan, and other related proposals. The document references these reports but does not contain the full reports themselves. It also mentions that these reports will be submitted to the shareholders' meeting for approval. The document is relatively short (3140 characters) and serves as an official announcement of the Supervisory Board's meeting resolutions rather than the reports themselves. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-04-23 Chinese
关于收到政府上市奖励的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (508 characters) about the company receiving government listing reward funds. It includes a guarantee of accuracy by the board and mentions accounting treatment to be confirmed by audit later. There is no financial statement, no detailed report, no earnings data, no management discussion, or other substantive financial content. It is an announcement of a government grant receipt, not a financial report or detailed filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a regulatory announcement about a government subsidy related to listing. Given the short length and nature, it fits best under Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2023-04-16 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.